Don't Jump to a CGRP Antagonist for Migraine Prophylaxis
December 2018
You'll see two new biologics to PREVENT migraine in adults, Ajovy (uh-JOH-vee, fremanezumab) and Emgality (em-GAL-ih-tee, galcanezumab).
They'll join Aimovig (erenumab)...the first calcitonin gene-related peptide blocker, or CGRP antagonist. Blocking CGRP limits vasodilation.
All are once-monthly, self-administered subcutaneous injections...or Ajovy can be given as 3 injections once every 3 months. Aimovig is an auto-injector...Ajovy is a prefilled syringe...Emgality is a pen.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote